Healthcare marketing pioneer Doceree and global adtech innovator Lemma have entered into an exclusive strategic supply partnership. The collaboration is designed to deliver true, contextually intelligent addressability to the pharmaceutical and life sciences sectors by bringing Lemma’s premium digital out-of-home (DOOH) media inventory exclusively into Doceree’s performance marketing network.
For decades, healthcare brands attempting to construct physical out-of-home marketing campaigns have faced a structural tradeoff between scale and geographic precision. Traditional outdoor advertising relies heavily on broad demographic estimations or historical foot-traffic averages, which frequently result in substantial ad spend waste. Because these generalist platforms lack insight into the unique compliance boundaries and rapid workflow shifts of modern clinical environments, life science companies have struggled to deliver messages that align with real-time medical needs.
Activating Physical Spaces via Real Clinical Intent
To eliminate this operational friction, the partnership layers Doceree’s proprietary, patented Triggers™ technology and Clinical Intent Signals (CIS) framework directly onto Lemma’s global programmatic DOOH network. This integration effectively converts traditional digital billboards, clinic displays, and pharmacy screens into context-aware communication surfaces that adapt dynamically to local healthcare events.
The software architecture triggers localized messaging based on immediate market variables:
-
Point-of-Care Synchronization: Coordinates public and clinical screen messaging with real-time patient-physician interactions occurring in nearby medical spaces.
-
Dynamic Localized Triggers: Activates specific, condition-focused creative assets automatically based on immediate medical data points, such as a localized surge in specialized consultations within a medical plaza.
-
Cross-Channel Alignment: Enables media buyers to plan, purchase, and adapt DOOH campaigns alongside electronic health records (EHR), point-of-care portals, and endemic digital publisher channels inside a single interface.
-
Closed-Loop Performance Tracking: Shifts reporting away from standard, top-of-funnel impression tracking toward verified behavioral outcomes and actual medical scripts filled.
“For two decades, healthcare marketers have had to choose between scale and precision in out-of-home,” said Harshit Jain, MD, Founder and Global CEO of Doceree. “As a physician, I know that the moments that matter in a patient journey don’t happen on a screen, they happen in waiting rooms, at pharmacies, in clinics. This partnership ensures that pharma marketers get not just reach, but reach engineered for clinical relevance.”
Also Read: Walmart Strengthens Retail Media With Vibe.co Acquisition
“Doceree’s Clinical Intent Signals framework is the most credible addressability layer we have seen in this space, and Trigger DOOH is the natural place to bring Lemma’s premium DOOH capabilities to pharma,” said Merlin Coutinho, speaking on behalf of Lemma. “At Lemma, transparency is a foundational core value. This exclusive partnership in healthcare naturally extends that ethos, ensuring a new standard where every impression a life science brand buys through our platform is engineered for true clinical relevance, not just reach.”
Expanding the Sovereign Infrastructure of Programmatic Medicine
The arrangement establishes Lemma as the exclusive DOOH supply-side engine for Doceree’s specialized healthcare out-of-home product within the United States. Under the terms of the agreement, Lemma’s premium medical and public screen inventories will be accessible to pharmaceutical brands and healthcare media agencies solely through the Doceree Trigger DOOH module.
By bypassing traditional open ad auctions and introducing strict category isolation, the integrated network ensures that every impression purchased by a life science brand is fully insulated from non-endemic ad clutter. Furthermore, the framework moves programmatic execution away from legacy zip-code averages and toward localized, intent-driven clinical software events.